Lidia Sambucetti Joins SRA International, Inc. to Lead Cancer Drug Discovery Programs

MENLO PARK, CA--(Marketwire - January 31, 2008) - SRI International, an independent nonprofit research and development organization, today announced that Lidia Sambucetti, Ph.D., has joined its Biosciences Division as senior director of cancer research. In her new role at SRI, Sambucetti will direct cancer drug discovery efforts, collaborating with scientific and business development colleagues to advance the translational research programs of the Biosciences Division.

MORE ON THIS TOPIC